Clay B. Siegall

Seattle Genetics

President and CEO

Overview

Clay B. Siegall received an average compensation of $6,107,632 at Seattle Genetics from 2006 to 2018.

Annual data

2018

In 2018, Clay B. Siegall earned a total compensation of $18,107,037 as President and CEO at Seattle Genetics.

Ranking131 out of 8,301
Percentile98.4%

Clay B. Siegall's 2018 compensation ranked 131st out of 8,301 executive pay records tracked by us this year.

Clay B. Siegall earned more than 98.4% of all executives tracked by us in 2018.

IndustryBiological products (no diagnostic substances)
Ranking1 out of 84
Percentile98.8%

In the industry of biological products (no diagnostic substances), Clay B. Siegall's 2018 pay ranked 1st, among 84 executive pay records.

Clay B. Siegall earned more than 98.8% of executives in this industry.

Bonus$2,000
Non-Equity Incentive Plan$1,409,995
Option Awards$7,539,792
Salary$918,554
Stock Awards$8,217,394
Other$19,302
Total$18,107,037

Siegall received $8,217,394 in stock awards, which accounts for 45.38% of total compensation.

Siegall also received $2,000 in bonus, $1,409,995 in non-equity incentive plan, $7,539,792 in option awards, $918,554 in salary and $19,302 in other compensation.

Clay B. Siegall's Pay$18,107,037
Median Employee's Pay$198,658
Pay Ratio91 : 1

For fiscal year 2018, the annual total compensation for Clay B. Siegall was $18,107,037 and for the median employee at Seattle Genetics was $198,658. The resulting ratio of Clay B. Siegall's pay to the pay of median employee was 91 to one.

2017

In 2017, Clay B. Siegall earned a total compensation of $8,616,344 as President and CEO at Seattle Genetics.

Ranking766 out of 13,165
Percentile94.2%

Clay B. Siegall's 2017 compensation ranked 766th out of 13,165 executive pay records tracked by us this year.

Clay B. Siegall earned more than 94.2% of all executives tracked by us in 2018.

IndustryBiological products (no diagnostic substances)
Ranking5 out of 227
Percentile97.8%

In the industry of biological products (no diagnostic substances), Clay B. Siegall's 2017 pay ranked 5th, among 227 executive pay records.

Clay B. Siegall earned more than 97.8% of executives in this industry.

Non-Equity Incentive Plan$934,500
Option Awards$3,217,921
Salary$887,146
Stock Awards$3,561,064
Other$15,713
Total$8,616,344

Siegall received $3,561,064 in stock awards, which accounts for 41.33% of total compensation.

Siegall also received $934,500 in non-equity incentive plan, $3,217,921 in option awards, $887,146 in salary and $15,713 in other compensation.

2016

In 2016, Clay B. Siegall earned a total compensation of $9,559,397 as President and CEO at Seattle Genetics.

Ranking548 out of 13,853
Percentile96.0%

Clay B. Siegall's 2016 compensation ranked 548th out of 13,853 executive pay records tracked by us this year.

Clay B. Siegall earned more than 96.0% of all executives tracked by us in 2018.

IndustryBiological products (no diagnostic substances)
Ranking7 out of 269
Percentile97.4%

In the industry of biological products (no diagnostic substances), Clay B. Siegall's 2016 pay ranked 7th, among 269 executive pay records.

Clay B. Siegall earned more than 97.4% of executives in this industry.

Non-Equity Incentive Plan$985,000
Option Awards$4,015,160
Salary$852,354
Stock Awards$3,686,600
Other$20,283
Total$9,559,397

Siegall received $4,015,160 in option awards, which accounts for 42.00% of total compensation.

Siegall also received $985,000 in non-equity incentive plan, $852,354 in salary, $3,686,600 in stock awards and $20,283 in other compensation.

2015

In 2015, Clay B. Siegall earned a total compensation of $6,871,245 as President and CEO at Seattle Genetics.

Ranking1,006 out of 13,574
Percentile92.6%

Clay B. Siegall's 2015 compensation ranked 1,006th out of 13,574 executive pay records tracked by us this year.

Clay B. Siegall earned more than 92.6% of all executives tracked by us in 2018.

IndustryBiological products (no diagnostic substances)
Ranking15 out of 248
Percentile94.0%

In the industry of biological products (no diagnostic substances), Clay B. Siegall's 2015 pay ranked 15th, among 248 executive pay records.

Clay B. Siegall earned more than 94.0% of executives in this industry.

Bonus$603
Non-Equity Incentive Plan$1,018,750
Option Awards$2,524,405
Salary$813,457
Stock Awards$2,505,600
Other$8,430
Total$6,871,245

Siegall received $2,524,405 in option awards, which accounts for 36.74% of total compensation.

Siegall also received $603 in bonus, $1,018,750 in non-equity incentive plan, $813,457 in salary, $2,505,600 in stock awards and $8,430 in other compensation.

2014

In 2014, Clay B. Siegall earned a total compensation of $6,863,212 as President and CEO at Seattle Genetics.

Ranking976 out of 12,876
Percentile92.4%

Clay B. Siegall's 2014 compensation ranked 976th out of 12,876 executive pay records tracked by us this year.

Clay B. Siegall earned more than 92.4% of all executives tracked by us in 2018.

IndustryBiological products (no diagnostic substances)
Ranking8 out of 221
Percentile96.4%

In the industry of biological products (no diagnostic substances), Clay B. Siegall's 2014 pay ranked 8th, among 221 executive pay records.

Clay B. Siegall earned more than 96.4% of executives in this industry.

Non-Equity Incentive Plan$646,800
Option Awards$2,803,482
Salary$759,250
Stock Awards$2,645,400
Other$8,280
Total$6,863,212

Siegall received $2,803,482 in option awards, which accounts for 40.85% of total compensation.

Siegall also received $646,800 in non-equity incentive plan, $759,250 in salary, $2,645,400 in stock awards and $8,280 in other compensation.

2013

In 2013, Clay B. Siegall earned a total compensation of $6,286,460 as President and CEO at Seattle Genetics.

Ranking918 out of 11,965
Percentile92.3%

Clay B. Siegall's 2013 compensation ranked 918th out of 11,965 executive pay records tracked by us this year.

Clay B. Siegall earned more than 92.3% of all executives tracked by us in 2018.

IndustryBiological products (no diagnostic substances)
Ranking5 out of 181
Percentile97.2%

In the industry of biological products (no diagnostic substances), Clay B. Siegall's 2013 pay ranked 5th, among 181 executive pay records.

Clay B. Siegall earned more than 97.2% of executives in this industry.

Bonus$1,500
Non-Equity Incentive Plan$652,000
Option Awards$2,644,713
Salary$722,917
Stock Awards$2,257,200
Other$8,130
Total$6,286,460

Siegall received $2,644,713 in option awards, which accounts for 42.07% of total compensation.

Siegall also received $1,500 in bonus, $652,000 in non-equity incentive plan, $722,917 in salary, $2,257,200 in stock awards and $8,130 in other compensation.

2012

In 2012, Clay B. Siegall earned a total compensation of $5,557,481 as President and CEO at Seattle Genetics.

Ranking1,041 out of 10,949
Percentile90.5%

Clay B. Siegall's 2012 compensation ranked 1,041st out of 10,949 executive pay records tracked by us this year.

Clay B. Siegall earned more than 90.5% of all executives tracked by us in 2018.

IndustryBiological products (no diagnostic substances)
Ranking5 out of 146
Percentile96.6%

In the industry of biological products (no diagnostic substances), Clay B. Siegall's 2012 pay ranked 5th, among 146 executive pay records.

Clay B. Siegall earned more than 96.6% of executives in this industry.

Non-Equity Incentive Plan$577,500
Option Awards$2,337,409
Salary$696,667
Stock Awards$1,937,925
Other$7,980
Total$5,557,481

Siegall received $2,337,409 in option awards, which accounts for 42.06% of total compensation.

Siegall also received $577,500 in non-equity incentive plan, $696,667 in salary, $1,937,925 in stock awards and $7,980 in other compensation.

2011

In 2011, Clay B. Siegall earned a total compensation of $4,893,175 as President and CEO at Seattle Genetics.

Ranking1,096 out of 10,035
Percentile89.1%

Clay B. Siegall's 2011 compensation ranked 1,096th out of 10,035 executive pay records tracked by us this year.

Clay B. Siegall earned more than 89.1% of all executives tracked by us in 2018.

IndustryBiological products (no diagnostic substances)
Ranking5 out of 137
Percentile96.4%

In the industry of biological products (no diagnostic substances), Clay B. Siegall's 2011 pay ranked 5th, among 137 executive pay records.

Clay B. Siegall earned more than 96.4% of executives in this industry.

Bonus$519
Non-Equity Incentive Plan$807,400
Option Awards$2,219,546
Salary$657,500
Stock Awards$1,200,380
Other$7,830
Total$4,893,175

Siegall received $2,219,546 in option awards, which accounts for 45.36% of total compensation.

Siegall also received $519 in bonus, $807,400 in non-equity incentive plan, $657,500 in salary, $1,200,380 in stock awards and $7,830 in other compensation.

2010

In 2010, Clay B. Siegall earned a total compensation of $3,217,344 as President and CEO at Seattle Genetics.

Ranking1,750 out of 9,477
Percentile81.5%

Clay B. Siegall's 2010 compensation ranked 1,750th out of 9,477 executive pay records tracked by us this year.

Clay B. Siegall earned more than 81.5% of all executives tracked by us in 2018.

IndustryBiological products (no diagnostic substances)
Ranking13 out of 129
Percentile89.9%

In the industry of biological products (no diagnostic substances), Clay B. Siegall's 2010 pay ranked 13th, among 129 executive pay records.

Clay B. Siegall earned more than 89.9% of executives in this industry.

Non-Equity Incentive Plan$472,500
Option Awards$2,109,258
Salary$627,696
Other$7,890
Total$3,217,344

Siegall received $2,109,258 in option awards, which accounts for 65.56% of total compensation.

Siegall also received $472,500 in non-equity incentive plan, $627,696 in salary and $7,890 in other compensation.

2009

In 2009, Clay B. Siegall earned a total compensation of $2,533,249 as President and CEO at Seattle Genetics.

Ranking1,727 out of 8,703
Percentile80.2%

Clay B. Siegall's 2009 compensation ranked 1,727th out of 8,703 executive pay records tracked by us this year.

Clay B. Siegall earned more than 80.2% of all executives tracked by us in 2018.

IndustryBiological products (no diagnostic substances)
Ranking10 out of 114
Percentile91.2%

In the industry of biological products (no diagnostic substances), Clay B. Siegall's 2009 pay ranked 10th, among 114 executive pay records.

Clay B. Siegall earned more than 91.2% of executives in this industry.

Non-Equity Incentive Plan$346,351
Option Awards$1,578,937
Salary$600,071
Other$7,890
Total$2,533,249

Siegall received $1,578,937 in option awards, which accounts for 62.33% of total compensation.

Siegall also received $346,351 in non-equity incentive plan, $600,071 in salary and $7,890 in other compensation.

2008

In 2008, Clay B. Siegall earned a total compensation of $2,315,515 as President and CEO at Seattle Genetics.

Ranking1,877 out of 7,730
Percentile75.7%

Clay B. Siegall's 2008 compensation ranked 1,877th out of 7,730 executive pay records tracked by us this year.

Clay B. Siegall earned more than 75.7% of all executives tracked by us in 2018.

IndustryBiological products (no diagnostic substances)
Ranking15 out of 105
Percentile85.7%

In the industry of biological products (no diagnostic substances), Clay B. Siegall's 2008 pay ranked 15th, among 105 executive pay records.

Clay B. Siegall earned more than 85.7% of executives in this industry.

Bonus$1,500
Non-Equity Incentive Plan$359,375
Option Awards$1,379,242
Salary$567,958
Other$7,440
Total$2,315,515

Siegall received $1,379,242 in option awards, which accounts for 59.57% of total compensation.

Siegall also received $1,500 in bonus, $359,375 in non-equity incentive plan, $567,958 in salary and $7,440 in other compensation.

2007

In 2007, Clay B. Siegall earned a total compensation of $3,579,260 as President and CEO at Seattle Genetics.

Ranking1,069 out of 6,983
Percentile84.7%

Clay B. Siegall's 2007 compensation ranked 1,069th out of 6,983 executive pay records tracked by us this year.

Clay B. Siegall earned more than 84.7% of all executives tracked by us in 2018.

IndustryBiological products (no diagnostic substances)
Ranking10 out of 100
Percentile90.0%

In the industry of biological products (no diagnostic substances), Clay B. Siegall's 2007 pay ranked 10th, among 100 executive pay records.

Clay B. Siegall earned more than 90.0% of executives in this industry.

Non-Equity Incentive Plan$264,870
Option Awards$2,823,000
Salary$486,025
Other$5,365
Total$3,579,260

Siegall received $2,823,000 in option awards, which accounts for 78.87% of total compensation.

Siegall also received $264,870 in non-equity incentive plan, $486,025 in salary and $5,365 in other compensation.

2006

In 2006, Clay B. Siegall earned a total compensation of $999,500 as President and CEO at Seattle Genetics.

Ranking2,472 out of 5,364
Percentile53.9%

Clay B. Siegall's 2006 compensation ranked 2,472nd out of 5,364 executive pay records tracked by us this year.

Clay B. Siegall earned more than 53.9% of all executives tracked by us in 2018.

IndustryBiological products (no diagnostic substances)
Ranking19 out of 93
Percentile79.6%

In the industry of biological products (no diagnostic substances), Clay B. Siegall's 2006 pay ranked 19th, among 93 executive pay records.

Clay B. Siegall earned more than 79.6% of executives in this industry.

Non-Equity Incentive Plan$206,388
Option Awards$352,347
Salary$435,400
Other$5,365
Total$999,500

Siegall received $435,400 in salary, which accounts for 43.56% of total compensation.

Siegall also received $206,388 in non-equity incentive plan, $352,347 in option awards and $5,365 in other compensation.